|
1
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lazebnik Y: What are the hallmarks of
cancer? Nat Rev Cancer. 10:232–233. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seyfried TN and Huysentruyt LC: On the
origin of cancer metastasis. Crit Rev Oncog. 18:43–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tannock IF and Rotin D: Acid pH in tumors
and its potential for therapeutic exploitation. Cancer Res.
49:4373–4384. 1989.PubMed/NCBI
|
|
5
|
Moellering RE, Black KC, Krishnamurty C,
Baggett BK, Stafford P, Rain M, Gatenby RA and Gillies RJ: Acid
treatment of melanoma cells selects for invasive phenotypes. Clin
Exp Metastasis. 25:411–425. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Estrella V, Chen T, Lloyd M, Wojtkowiak J,
Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg
JM, Sloane BF, et al: Acidity generated by the tumor
microenvironment drives local invasion. Cancer Res. 73:1524–1535.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gatenby RA and Gillies RJ: A
microenvironmental model of carcinogenesis. Nat Rev Cancer.
8:56–61. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peppicelli S, Bianchini F, Torre E and
Calorini L: Contribution of acidic melanoma cells undergoing
epithelial-to-mesenchymal transition to aggressiveness of
non-acidic melanoma cells. Clin Exp Metastasis. 31:423–433. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hjelmeland AB, Wu Q, Heddleston JM,
Choudhary GS, MacSwords J, Lathia JD, McLendon R, Lindner D, Sloan
A and Rich JN: Acidic stress promotes a glioma stem cell phenotype.
Cell Death Differ. 18:829–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sevenich L and Joyce JA: Pericellular
proteolysis in cancer. Genes Dev. 28:2331–2347. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Darmoul D, Gratio V, Devaud H, Peiretti F
and Laburthe M: Activation of proteinase-activated receptor 1
promotes human colon cancer cell proliferation through epidermal
growth factor receptor transactivation. Mol Cancer Res. 2:514–522.
2004.PubMed/NCBI
|
|
12
|
Darmoul D, Marie JC, Devaud H, Gratio V
and Laburthe M: Initiation of human colon cancer cell proliferation
by trypsin acting at protease-activated receptor-2. Br J Cancer.
85:772–779. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gratio V, Loriot C, Virca GD,
Oikonomopoulou K, Walker F, Diamandis EP, Hollenberg MD and Darmoul
D: Kallikrein-related peptidase 14 acts on proteinase-activated
receptor 2 to induce signaling pathway in colon cancer cells. Am J
Pathol. 179:2625–2636. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ramsay AJ, Reid JC, Adams MN, Samaratunga
H, Dong Y, Clements JA and Hooper JD: Prostatic trypsin-like
kallikrein-related peptidases (KLKs) and other prostate-expressed
tryptic proteinases as regulators of signalling via
proteinase-activated receptors (PARs). Biol Chem. 389:653–668.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Loessner D, Goettig P, Preis S, Felber J,
Bronger H, Clements JA, Dorn J and Magdolen V: Kallikrein-related
peptidases represent attractive therapeutic targets for ovarian
cancer. Expert Opin Ther Targets. 22:745–763. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Avgeris M and Scorilas A:
Kallikrein-related peptidases (KLKs) as emerging therapeutic
targets: Focus on prostate cancer and skin pathologies. Expert Opin
Ther Targets. 20:801–818. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kryza T, Silva ML, Loessner D,
Heuze-Vourc'h N and Clements JA: The kallikrein-related peptidase
family: Dysregulation and functions during cancer progression.
Biochimie. 122:283–299. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shaw JL and Diamandis EP: Distribution of
15 human kallikreins in tissues and biological fluids. Clin Chem.
53:1423–1432. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hong R and Han SI: Extracellular acidity
enhances tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL)-mediated apoptosis via DR5 in gastric cancer cells. Korean
J Physiol Pharmacol. 22:513–523. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang L and Han X: The urokinase
plasminogen activator system in breast cancer invasion and
metastasis. Biomed Pharmacother. 67:179–182. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Duffy MJ: The role of proteolytic enzymes
in cancer invasion and metastasis. Clin Exp Metastasis. 10:145–155.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Caubet C, Jonca N, Brattsand M, Guerrin M,
Bernard D, Schmidt R, Egelrud T, Simon M and Serre G: Degradation
of corneodesmosome proteins by two serine proteases of the
kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest
Dermatol. 122:1235–1244. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Komatsu N, Saijoh K, Kuk C, Liu AC, Khan
S, Shirasaki F, Takehara K and Diamandis EP: Human tissue
kallikrein expression in the stratum corneum and serum of atopic
dermatitis patients. Exp Dermatol. 16:513–519. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Descargues P, Deraison C, Bonnart C, Kreft
M, Kishibe M, Ishida-Yamamoto A, Elias P, Barrandon Y, Zambruno G,
Sonnenberg A and Hovnanian A: Spink5-deficient mice mimic Netherton
syndrome through degradation of desmoglein 1 by epidermal protease
hyperactivity. Nat Genet. 37:56–65. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ekholm E and Egelrud T: Stratum corneum
chymotryptic enzyme in psoriasis. Arch Dermatol Res. 291:195–200.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dorn J, Gkazepis A, Kotzsch M, Kremer M,
Propping C, Mayer K, Mengele K, Diamandis EP, Kiechle M, Magdolen V
and Schmitt M: Clinical value of protein expression of
kallikrein-related peptidase 7 (KLK7) in ovarian cancer. Biol Chem.
395:95–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Devetzi M, Trangas T, Scorilas A,
Xynopoulos D and Talieri M: Parallel overexpression and clinical
significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14)
in colon cancer. Thromb Haemost. 109:716–725. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iakovlev V, Siegel ER, Tsao MS and Haun
RS: Expression of kallikrein-related peptidase 7 predicts poor
prognosis in patients with unresectable pancreatic ductal
adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 21:1135–1142.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rezze GG, Fregnani JH, Duprat J and
Landman G: Cell adhesion and communication proteins are
differentially expressed in melanoma progression model. Hum Pathol.
42:409–418. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Talieri M, Mathioudaki K, Prezas P,
Alexopoulou DK, Diamandis EP, Xynopoulos D, Ardavanis A,
Arnogiannaki N and Scorilas A: Clinical significance of
kallikrein-related peptidase 7 (KLK7) in colorectal cancer. Thromb
Haemost. 101:741–747. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Johnson SK, Ramani VC, Hennings L and Haun
RS: Kallikrein 7 enhances pancreatic cancer cell invasion by
shedding E-cadherin. Cancer. 109:1811–1820. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Delaunay T, Deschamps L, Haddada M, Walker
F, Soosaipillai A, Soualmia F, El Amri C, Diamandis EP, Brattsand
M, Magdolen V and Darmoul D: Aberrant expression of
kallikrein-related peptidase 7 is correlated with human melanoma
aggressiveness by stimulating cell migration and invasion. Mol
Oncol. 11:1330–1347. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kishi T, Grass L, Soosaipillai A,
Shimizu-Okabe C and Diamandis EP: Human kallikrein 8: Immunoassay
development and identification in tissue extracts and biological
fluids. Clin Chem. 49:87–96. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Planque C, Choi YH, Guyetant S,
Heuze-Vourc'h N, Briollais L and Courty Y: Alternative splicing
variant of kallikrein-related peptidase 8 as an independent
predictor of unfavorable prognosis in lung cancer. Clin Chem.
56:987–997. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Darling MR, Tsai S, Jackson-Boeters L,
Daley TD and Diamandis EP: Human kallikrein 8 expression in
salivary gland tumors. Head Neck Pathol. 2:169–174. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cane S, Bignotti E, Bellone S, Palmieri M,
De las Casas L, Roman JJ, Pecorelli S, Cannon MJ, O'brien T and
Santin AD: The novel serine protease tumor-associated
differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly
overexpressed in cervical cancer. Am J Obstet Gynecol. 190:60–66.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Magklara A, Scorilas A, Katsaros D,
Massobrio M, Yousef GM, Fracchioli S, Danese S and Diamandis EP:
The human KLK8 (neuropsin/ovasin) gene: Identification of two novel
splice variants and its prognostic value in ovarian cancer. Clin
Cancer Res. 7:806–811. 2001.PubMed/NCBI
|
|
40
|
Zhuang GF, Tan Y, Yang YZ, Zhang JW and
Tang J: Experiment research of cisplatin implants inhibiting
transplantation tumor growth and regulating the expression of KLK7
and E-cad of tumor-bearing mice with gastric cancer. Asian Pac J
Trop Med. 9:606–609. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yu Y, Prassas I, Dimitromanolakis A and
Diamandis EP: Novel biological substrates of human kallikrein 7
identified through degradomics. J Biol Chem. 290:17762–17775. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Martins WK, Esteves GH, Almeida OM, Rezze
GG, Landman G, Marques SM, Carvalho AF, L Reis LF, Duprat JP and
Stolf BS: Gene network analyses point to the importance of human
tissue kallikreins in melanoma progression. BMC Med Genomics.
4:762011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Borgono CA, Kishi T, Scorilas A, Harbeck
N, Dorn J, Schmalfeldt B, Schmitt M and Diamandis EP: Human
kallikrein 8 protein is a favorable prognostic marker in ovarian
cancer. Clin Cancer Res. 12:1487–1493. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ahmed N, Dorn J, Napieralski R, Drecoll E,
Kotzsch M, Goettig P, Zein E, Avril S, Kiechle M, Diamandis EP, et
al: Clinical relevance of kallikrein-related peptidase 6 (KLK6) and
8 (KLK8) mRNA expression in advanced serous ovarian cancer. Biol
Chem. 397:1265–1276. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cha SH, Park JE, Kwak JO, Kim HW, Kim JB,
Lee KY and Cha YN: Attenuation of extracellular acidic pH-induced
cyclooxygenase-2 expression by nitric oxide. Mol Cells. 19:232–238.
2005.PubMed/NCBI
|
|
46
|
Riemann A, Ihling A, Thomas J, Schneider
B, Thews O and Gekle M: Acidic environment activates inflammatory
programs in fibroblasts via a cAMP-MAPK pathway. Biochim Biophys
Acta. 1853:299–307. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dong L, Li Z, Leffler NR, Asch AS, Chi JT
and Yang LV: Acidosis activation of the proton-sensing GPR4
receptor stimulates vascular endothelial cell inflammatory
responses revealed by transcriptome analysis. PLoS One.
8:e619912013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Etulain J, Negrotto S, Carestia A, Pozner
RG, Romaniuk MA, D'Atri LP, Klement GL and Schattner M: Acidosis
downregulates platelet haemostatic functions and promotes
neutrophil proinflammatory responses mediated by platelets. Thromb
Haemost. 107:99–110. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Naghavi M, John R, Naguib S, Siadaty MS,
Grasu R, Kurian KC, van Winkle WB, Soller B, Litovsky S, Madjid M,
et al: pH Heterogeneity of human and rabbit atherosclerotic
plaques; a new insight into detection of vulnerable plaque.
Atherosclerosis. 164:27–35. 2002. View Article : Google Scholar : PubMed/NCBI
|
